Allianz Research Institute, Inc.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma2 trials
• COPD1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Genentech, Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma

  NCT07746687· Phase 2· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Asthma1 recruiting

Closed trials

• Completed

  A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

  NCT05037929· Phase 2· Genentech, Inc.· Source

• Completed

  Registry of Asthma Patients Initiating DUPIXENT®

  NCT04287621· Regeneron Pharmaceuticals· Source